In the last decade, research has elucidated a significant involvement of versican in tumors and neurodegenerative diseases; these observations, coupled with those demonstrating that versican regulates many of the events that contribute to the poor prognosis of cancer and neurodegeneration, highlight the critical importance of versican in the pathogenesis of disease [29–35]. This evidence concerns the gene VCAN and neurodegenerative disease.